Modern lifestyles have changed eating behavior faster than our bodies can adapt. In just the past 30 years, eating on the run, ever increasing portion sizes and less physical activity have contributed to a near doubling of overweight and obese people in the world. Simply put, people eat too quickly and eat too much before they feel full – or satisfied. SmartByte™ is not a diet, meal replacement or lecture program. It is a scientifically proven tool that can help you eat slower and consume fewer calories. SmartByte™ changes how you eat, not what you eat. It allows you to feel satisfied from your meal after consuming less food.
SmartByte™ is a safe, removable, custom made oral device that is placed comfortably in the upper palate (the roof of the mouth) only while eating. SmartByte™ combines five modes of action to achieve weight loss:
- It makes you take smaller bites, slowing food intake.
- It requires thorough chewing of food before swallowing.
- It ends “gulping” or “wolfing” of food.
- By slowing the eating process, it permits more appreciation (savoring) of the taste, smell and texture of food.
- By slowing food intake, it permits triggering of the body’s built-in satiety response when one has eaten less food, so users feel satisfied, but on less calories.
Embedded in SmartByte™ is a small sensor that acts like an “automatic journal,” tracking success by recording usage every day. Simply place SmartByte™ in its reader and attach the USB cord to any PC. This unique feature accurately measures your progress to weight loss goals. SmartByte™ was developed after observing the eating habits of people with a naturally occurring condition called Torus Palatinus. People with this condition in the mouth are rarely overweight. Torus Palatinus decreases volume in the palatal area of the oral cavity resulting in the changes in listed above. It does this without pharmaceuticals, surgery or side effects.
A large body of scientific research has linked rapid eating to overweight and obesity. SmartByte™ has been evaluated in several clinical trials confirming the safety and efficacy for a large subset of the BMI 27 – 35 population.